Does Security Health Plan Cover Wegovy?
The verdict
Conditional on most plans
Security Health Plan's Wegovy coverage for weight loss is employer-dependent and not publicly published. The plan is affiliated with Marshfield Clinic, a large integrated health system in Wisconsin — but integrated delivery does not change the coverage gate: weight-loss Wegovy is covered only where the employer group purchased the anti-obesity benefit. This is a similar posture to sibling Wisconsin plans Network Health and Quartz, differentiated by the Marshfield-affiliated delivery model.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Security Health Plan using your member ID.
Key facts
Security Health Plan is affiliated with Marshfield Clinic, a large integrated health system in Wisconsin — but Marshfield integration does not automatically include anti-obesity drug coverage; employer benefit design still decides.
Security Health Plan plan materials
Wegovy's list price is $1,349/month; Novo Nordisk announced a reduction to approximately $675/month effective January 1, 2027.
Novo Nordisk press release, 2026
The Medicare GLP-1 Bridge launches July 1, 2026, giving eligible Medicare beneficiaries Wegovy weight-loss access at $50/month outside Part D — not counting toward the $2,100 OOP cap.
CMS.gov, Medicare GLP-1 Weight Loss Drug Access Program
Medicare vs. commercial coverage
Whether Security Health Plan covers Wegovy depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Medicare Part D cannot cover Wegovy for weight loss by statute — this applies to all Security Health Plan Medicare plans. Security Health Plan Medicare plans can cover Wegovy for the cardiovascular risk-reduction indication (FDA-approved for adults with established CVD who are overweight or obese) with prior authorization. The Medicare GLP-1 Bridge launches July 1, 2026, giving eligible Medicare beneficiaries weight-loss access to Wegovy at $50/month through December 31, 2027 — this operates outside Part D, so the $50 does not count toward the $2,100 OOP cap or TrOOP. Extra Help cannot be applied to Bridge copays. NovoCare savings card is not available to Medicare beneficiaries.
Commercial / Employer
Group & marketplace plans
Security Health Plan commercial and employer plans cover Wegovy for weight loss only when the employer has purchased the anti-obesity benefit. Where the benefit is included, prior authorization is required: BMI 30 or higher, or BMI 27 or higher with a weight-related comorbidity (hypertension, type 2 diabetes, dyslipidemia, or obstructive sleep apnea), plus documented lifestyle program participation and weight-loss maintenance for renewal. If the employer did not opt in, weight-loss Wegovy is excluded — this is a benefit design decision, not a medical-necessity denial. ACA/individual-market plans generally exclude Wegovy for weight loss. Wisconsin Medicaid GLP-1 obesity coverage is state-dependent; verify on the WI Medicaid PDL. Per-plan drug tier and cost-share are not publicly published at the drug level — verify via Security Health Plan's drug-lookup tool. Commercially insured members whose plan covers Wegovy may use the NovoCare savings card at $25/month (max $100 per 28-day supply; not available to Medicare or Medicaid).
The 4 boxes you must tick to get approved
Commercial plans that will consider Wegovy require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
Meet all 4 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Wegovy actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
$1,349/month (Novo Nordisk published list price for a 28-day supply). NovoCare self-pay: approximately $349/month for standard injection doses after an introductory period through December 31, 2026.
List price with no coverage — before any manufacturer savings card.
With coverage
Plan-specific cost-share where covered — not publicly published at the drug level. Confirm your specific cost-share on Security Health Plan's drug-lookup tool or member portal. NovoCare savings card: commercially insured members whose plan covers Wegovy may pay as little as $25/month (max $100 per 28-day supply). Not available to Medicare or Medicaid beneficiaries.
Typical monthly copay once prior authorization is approved.
Bridge program
Medicare GLP-1 Bridge: $50/month fixed copay for eligible Medicare beneficiaries, launching July 1, 2026, through December 31, 2027. Operates outside Part D — does not count toward the $2,100 OOP cap, TrOOP, or Extra Help. Provider must attest eligibility at initiation.
Reduced copay through the assistance program, where eligible.
All cost figures are estimates. Actual cost-share varies by plan tier, deductible phase, and pharmacy — confirm with your Security Health Plan and pharmacist before starting treatment.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Ask HR whether your employer included the anti-obesity benefit
Being a Security Health Plan member affiliated with Marshfield Clinic does not automatically include anti-obesity drug coverage. Confirm with your HR benefits team whether weight-loss medications are in your employer plan. If excluded, no PA will succeed — it is a benefit design decision.
- 2
Search Security Health Plan's drug-lookup tool for your specific plan
Go to securityhealthplan.com and use the formulary or drug-lookup tool with your member ID. Search for 'Wegovy' or 'semaglutide 2.4 mg' to confirm tier, PA requirements, and quantity limits for your actual plan.
- 3
Work with your Marshfield Clinic or other prescriber on prior authorization
If your plan covers Wegovy, your prescriber (whether a Marshfield Clinic provider or otherwise) will submit a PA to Security Health Plan. Gather documentation: BMI measurement, relevant comorbidities, and evidence of lifestyle program participation. Track weight-loss progress before each renewal to meet the reauthorization threshold.
Options if Security Health Plan won't cover Wegovy
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Ozempic (semaglutide for T2D)
If you have type 2 diabetes, Ozempic (semaglutide) is broadly covered for T2D with PA across most commercial plans regardless of the anti-obesity benefit. Ozempic is not FDA-approved for weight loss and should not be prescribed for that indication.
NovoCare self-pay program
Novo Nordisk's NovoCare Pharmacy offers Wegovy at approximately $349/month for patients without coverage. An introductory rate of approximately $199/month applies to the 0.25 and 0.5 mg doses through December 31, 2026. List price is announced to drop to approximately $675/month effective January 1, 2027.
Compounded semaglutide
Compounded semaglutide is available without insurance for patients who cannot access covered Wegovy. See the Curex offer below. Compounded medications are not the same as Wegovy and have not been approved by the FDA.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
Security Health Plan covers Wegovy for weight loss only on employer plans where the anti-obesity benefit was purchased. Drug-level Wegovy detail is not publicly published — verify on the drug-lookup tool at securityhealthplan.com or by calling member services. ACA/individual plans generally exclude weight-loss GLP-1s. Being part of the Marshfield Clinic integrated system does not automatically include anti-obesity drug coverage; that is determined by your specific employer's benefit design.
Both Security Health Plan and Network Health are Wisconsin regional plans with not-publicly-published Wegovy detail gating weight-loss coverage on employer opt-in. The distinguishing feature is delivery model: Security Health Plan is affiliated with Marshfield Clinic, an integrated health system, while Network Health is an independent commercial insurer with a notable Medicare Advantage book. For commercial weight-loss seekers, the coverage logic is the same — employer benefit design decides — but Security Health Plan members with complex chronic conditions may benefit from Marshfield's integrated prescribing relationship when navigating the PA process.
Where the anti-obesity benefit is included, Security Health Plan requires PA with BMI 30 or higher (or 27 with a weight-related comorbidity such as hypertension, T2D, dyslipidemia, or sleep apnea), documented lifestyle program participation, and demonstrated weight-loss progress for renewal. Specific Security Health Plan PA criteria are not publicly published — confirm current requirements with member services or your prescriber before submitting.
No. Medicare Part D cannot cover Wegovy for weight loss by statute — this is a federal rule applying to all plans including Security Health Plan Medicare plans. Security Health Plan Medicare plans can cover Wegovy for the cardiovascular risk-reduction indication in members with established CVD. The Medicare GLP-1 Bridge (launching July 1, 2026) provides weight-loss access at $50/month outside Part D for eligible beneficiaries — verify Bridge eligibility criteria with your prescriber.
Being cared for at Marshfield Clinic can streamline the prior authorization process because your prescriber has integrated access to your health records, making it easier to document BMI, comorbidities, and lifestyle program participation. However, the coverage decision itself — whether your employer plan includes the anti-obesity benefit — is entirely independent of the Marshfield delivery system. An integrated prescriber cannot override a benefit design exclusion. What the integrated system helps with is the paperwork once you confirm the benefit exists.
Related Articles
Does Quartz Health Solutions Cover Wegovy? 2026 | Curex
Quartz Health Solutions covers Wegovy only where your employer opted into the anti-obesity benefit. Not publicly published — verify on Quartz's formulary.
Read moreDoes Security Health Plan Cover Mounjaro? 2026 | Curex
Security Health Plan (WI) covers Mounjaro for type 2 diabetes with prior auth — not weight loss. Composite pattern; verify on plan formulary.
Read moreDoes Geisinger Health Plan Cover Wegovy? 2026 | Curex
Geisinger Wegovy coverage is employer-dependent and unpublished. PA Medicaid dropped GLP-1 obesity coverage in 2026. How to verify.
Read moreDoes Group Health Cooperative Cover Wegovy? 2026 | Curex
Group Health Cooperative covers Wegovy only where your employer opted in. Wisconsin co-op — drug-level detail not public. Verify on GHC's drug-lookup tool.
Read moreDoes UPMC Health Plan Cover Wegovy? PA Plans 2026 | Curex
UPMC covers Wegovy for weight loss only where employers opted in. PA Medicaid dropped GLP-1 obesity coverage January 2026. Verify on UPMC drug lookup.
Read moreDoes Harvard Pilgrim Health Care Cover Wegovy? 2026 | Curex
Harvard Pilgrim covers Wegovy only where your employer opted in. New England GLP-1 market tightening — BCBS-MA exited 2026. Verify on the drug-lookup tool.
Read moreWhether or not Security Health Plan covers Wegovy, there's a path that skips insurance
Security Health Plan covers Wegovy for weight loss only where the employer opted in. For patients without that benefit, Curex offers compounded semaglutide from $49/mo (compounded tirzepatide from $149/mo) at getcurex.com/cl/glp — no insurance, no prior authorization. Compounded semaglutide is not the same medication as Wegovy. Prescription required, subject to provider review.
- Medication + free shipping
- 24/7 provider access
- Medical intake & prescription review
Compounded semaglutide and tirzepatide are not the same medications as Wegovy and are not branded or FDA-approved products. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.
This content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Security Health Plan before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation. Curex offers compounded semaglutide and tirzepatide, which are not the same medications as Wegovy and are not branded or FDA-approved products; prescription required, subject to provider review. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.